United Therapeutics (UTHR) Capital Leases (2009)

United Therapeutics (UTHR) reported Capital Leases of $30.3 million for Q4 2009.

United Therapeutics (UTHR) Capital Leases (2009) Analysis & Trends

United Therapeutics (UTHR) has 1 years of Capital Leases data on file, last reported at $30.3 million in Q4 2009.

For the quarter ending Q4 2009, Capital Leases changed N/A year-over-year to $30.3 million; the trailing twelve-month figure through Dec 2009 stood at $30.3 million (changed N/A YoY), and the FY2009 full-year result was $30.3 million, changed N/A from the prior year.
Capital Leases held at $30.3 million in Q4 2009.
In the past five years, Capital Leases ranged from a high of $30.3 million in Q4 2009 to a low of $30.3 million in Q4 2009.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Vireo Growth	10.57 Bn	10.41 Bn	59.30 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2009	30.33 Mn